Factor XIII (FXIII) is a plasma proenzym, which stabilizers fibrin clots and plays key role in hemostasis. Here we report a case of acquired FXIII deficiency caused by FXIII inhibitor, which is rare and pathogenisis is still unknown. Experience of treatment is limited to data from case reports.
No takes yet. Share an insight, caveat, or question.
Tao Sui (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: